Bnp Paribas Asset Management Holding S.A. Arrowhead Pharmaceuticals, Inc. Put Options Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARWR
# of Institutions
330Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$621 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$615 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$420 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$252 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$207 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.19B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...